ResonanceDx is pioneering a device that can detect targeted antigens using any biofluid. A small, disposable and inexpensive USB acoustic sensor is coated in antibodies. When exposed to a sample of patient biofluid, the antibodies interact with corresponding antigens, producing a resonance that registers on the highly sensitive device.
The versatility of the ResonanceDx technology opens possibilities for use in many areas of medicine, from early detection of cancer to measuring clinical biomarkers to diagnosing bacterial or viral infections, such as SARS-CoV-2.
The global need for rapid, accurate, and cheap antigen testing is immense and growing. Able to return results in five minutes, ResonanceDx’s antigen testing platform is faster and easier to use than any existing test.
Company website: ResonanceDx
Back to companies